Clinical Trials Directory

Trials / Completed

CompletedNCT02504138

A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Hepatic Protection During Living-donor Liver Transplantation

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
136 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Renal ischemia/reperfusion (I/R)-induced injury is known to be associated with immediate and long-term hepatic dysfunction after liver transplantation. Protecting the liver against I/R injury and maintaining hepatic function during transplant surgery is therefore very important in order to improve post-operative outcome. This purpose of this study is to investigate whether propofol anesthesia done in both liver donors and recipients during living-donor liver transplantation is effective in reducing liver I/R injury via its antioxidant and antiinflammatory properties and improve post-transplant outcome compared to desflurane anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGDesflurane balanced anesthesiaDesflurane balanced anesthesia induced with thiopental sodium, remifentanil and atracurium and maintained with remifentanil target controlled infusion and desflurane inhalation
DRUGPropofol total intravenous anesthesiaPropofol total intravenous anesthesia induced with propofol, remifentanil and atracurium and maintained with remifentanil and propofol target controlled infusion

Timeline

Start date
2014-06-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2015-07-21
Last updated
2017-07-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02504138. Inclusion in this directory is not an endorsement.